"...Seen it before ..", earlier this year I've seen Merck buying VLA for over half a billion, that was almost a 170% premium to the sp at the time it was announced, then a few weeks later I have seen PerkinElmer buying RHS at a 100% premium to its last closing price:
being conservative, BOT next year - following good results from two phase2 trials (and with more products advancing) - shall have a MC of around $200m + (say sp 265c - being conservative) gets a big pharma offer with a 150% premium = 40c per share or about.
Seen it before.
"...Seen it before ..", earlier this year I've seen Merck buying...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.0¢ | $391.8K | 1.080M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 160000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 11013 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
